biote Corp

Company Profile

biote Corp had its IPO on 2021-04-28 under the ticker symbol BTMD.

The company operates in the Healthcare sector and Medical Care Facilities industry. biote Corp has a staff strength of 186 employees.

Stock update

Shares of biote Corp opened at $4.9 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.9 - $5.1, and closed at $5.

This is a +1.83% increase from the previous day's closing price.

A total volume of 383,887 shares were traded at the close of the day’s session.

In the last one week, shares of biote Corp have increased by +1.01%.

biote Corp's Key Ratios

biote Corp has a market cap of $398.83 million, indicating a price to book ratio of 2.9604 and a price to sales ratio of 0.2293.

In the last 12-months biote Corp’s revenue was $172.66 million with a gross profit of $90.58 million and an EBITDA of $-61450000. The EBITDA ratio measures biote Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, biote Corp’s operating margin was -36.26% while its return on assets stood at -43.83% with a return of equity of 0%.

In Q1, biote Corp’s quarterly earnings growth was a positive 5.8% while revenue growth was a positive 20.7%.

biote Corp’s PE and PEG Ratio

Forward PE

7.2046

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.95 per share while it has a forward price to earnings multiple of 7.2046 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into biote Corp’s profitability.

biote Corp stock is trading at a EV to sales ratio of 0.4946 and a EV to EBITDA ratio of 1.4421. Its price to sales ratio in the trailing 12-months stood at 0.2293.

biote Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$119.14 million

Total Liabilities

$19.86 million

Operating Cash Flow

$-380000.00

Capital Expenditure

$380000

Dividend Payout Ratio

0%

biote Corp ended 2024 with $119.14 million in total assets and $0 in total liabilities. Its intangible assets were valued at $119.14 million while shareholder equity stood at $-48538000.00.

biote Corp ended 2024 with $57.52 million in deferred long-term liabilities, $19.86 million in other current liabilities, 6000.00 in common stock, $-48532000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $87.61 million and cash and short-term investments were $87.61 million. The company’s total short-term debt was $6,467,000 while long-term debt stood at $110.72 million.

biote Corp’s total current assets stands at $107.46 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.65 million compared to accounts payable of $5.06 million and inventory worth $9.62 million.

In 2024, biote Corp's operating cash flow was $-380000.00 while its capital expenditure stood at $380000.

Comparatively, biote Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$5

52-Week High

$7.12

52-Week Low

$2

Analyst Target Price

$11.33

biote Corp stock is currently trading at $5 per share. It touched a 52-week high of $7.12 and a 52-week low of $7.12. Analysts tracking the stock have a 12-month average target price of $11.33.

Its 50-day moving average was $6.05 and 200-day moving average was $5.27 The short ratio stood at 4.32 indicating a short percent outstanding of 0%.

Around 1660.9% of the company’s stock are held by insiders while 2815.9% are held by institutions.